{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:58:17Z","timestamp":1785167897737,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"DOI":"10.7759\/cureus.54775","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T23:02:14Z","timestamp":1708729334000},"source":"Crossref","is-referenced-by-count":7,"title":["Varicella-Zoster Meningitis and Myelitis After Herpes Zoster Dermatitis Treatment With Amenamevir: A Case Series and Literature Review"],"prefix":"10.7759","author":[{"given":"Satoru","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishigaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Hazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/589747","article-title":"The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"47","author":"Tunkel AR","year":"2008","unstructured":"Tunkel AR, Glaser CA, Bloch KC, et al.. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008, 47:303-27. 10.1086\/589747","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.5692\/clinicalneurol.cn-001302","article-title":"Varicella-zoster virus-associated polyradiculoneuritis with concomitant herpes zoster eruption: a case report. [Article in Japanese]","volume":"59","author":"Shoji H","year":"2019","unstructured":"Shoji H, Fukushima Y, Sakoda Y, Abe T, Oguri S, Baba M. Varicella-zoster virus-associated polyradiculoneuritis with concomitant herpes zoster eruption: a case report. [Article in Japanese]. Rinsho Shinkeigaku. 2019, 59:641-5.","journal-title":"Rinsho Shinkeigaku"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.5692\/clinicalneurol.cn-001462","article-title":"Multiple cerebral hemorrhages due to varicella-zoster virus vasculopathy presenting as cranial nerve palsy. [Article in Japanese]","volume":"60","author":"Mukai T","year":"2020","unstructured":"Mukai T, Saiga T, Araki T. Multiple cerebral hemorrhages due to varicella-zoster virus vasculopathy presenting as cranial nerve palsy. [Article in Japanese]. Rinsho Shinkeigaku. 2020, 60:861-4.","journal-title":"Rinsho Shinkeigaku"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001531","article-title":"Varicella-zoster meningoencephalitis and vasculitis after treatment with amenamevir to herpes zoster in the trigeminal nerve area. [Article in Japanese]","volume":"61","author":"Taniguchi Y","year":"2021","unstructured":"Taniguchi Y, Kano Y, Kitamura T, Miura T, Yamada K. Varicella-zoster meningoencephalitis and vasculitis after treatment with amenamevir to herpes zoster in the trigeminal nerve area. [Article in Japanese]. Rinsho Shinkeigaku. 2021, 61:239-42. 10.5692\/clinicalneurol.cn-001531","journal-title":"Rinsho Shinkeigaku"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8581-21","article-title":"Aseptic meningitis after amenamevir treatment for herpes zoster in the first branch of the trigeminal nerve","volume":"61","author":"Itoh K","year":"2022","unstructured":"Itoh K, Mitsuke Y, Wakahara M, et al.. Aseptic meningitis after amenamevir treatment for herpes zoster in the first branch of the trigeminal nerve. Intern Med. 2022, 61:2809-11. 10.2169\/internalmedicine.8581-21","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.12.008","article-title":"Aseptic meningitis after amenamevir treatment for herpes zoster ophthalmicus with oculomotor nerve palsy in a patient taking immunosuppressant","volume":"29","author":"Omiya M","year":"2023","unstructured":"Omiya M, Nishiguchi S, Moriya H, Akazawa K, Nagahiro T, Seto M. Aseptic meningitis after amenamevir treatment for herpes zoster ophthalmicus with oculomotor nerve palsy in a patient taking immunosuppressant. J Infect Chemother. 2023, 29:519-22. 10.1016\/j.jiac.2022.12.008","journal-title":"J Infect Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000258549.13334.16","article-title":"The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy","volume":"68","author":"Nagel MA","year":"2007","unstructured":"Nagel MA, Forghani B, Mahalingam R, et al.. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007, 68:1069-73. 10.1212\/01.wnl.0000258549.13334.16","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/v13081547","article-title":"Amenamevir, a helicase-primase inhibitor, for the optimal treatment of herpes zoster","volume":"13","author":"Shiraki K","year":"2021","unstructured":"Shiraki K, Yasumoto S, Toyama N, Fukuda H. Amenamevir, a helicase-primase inhibitor, for the optimal treatment of herpes zoster. Viruses. 2021, 13:1547. 10.3390\/v13081547","journal-title":"Viruses"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-018-0481-y","article-title":"Absorption, distribution, metabolism, and excretion of the novel helicase-primase inhibitor, amenamevir (ASP2151), in rodents","volume":"43","author":"Ohtsu Y","year":"2018","unstructured":"Ohtsu Y, Susaki Y, Noguchi K. Absorption, distribution, metabolism, and excretion of the novel helicase-primase inhibitor, amenamevir (ASP2151), in rodents. Eur J Drug Metab Pharmacokinet. 2018, 43:693-706. 10.1007\/s13318-018-0481-y","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90088-2","article-title":"Overview of acyclovir pharmacokinetic disposition in adults and children","volume":"73","author":"Robert Blum M","year":"1982","unstructured":"Robert Blum M, Liaq SHT, De Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med. 1982, 73:186-92. 10.1016\/0002-9343(82)90088-2","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-04404-2.10027-2","article-title":"Immune responses to viruses","author":"Mueller SN","year":"2008","unstructured":"Mueller SN, Rouse BT. Immune responses to viruses. Clinical Immunology (Third Edition). Elsevier, 2008. 421-31. 10.1016\/B978-0-323-04404-2.10027-2"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen T","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N Engl J Med. 2005, 353:1711-23. 10.1056\/NEJMra050541","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka Y","year":"2022","unstructured":"Tanaka Y, Luo Y, O'Shea JJ, Nakayamada S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat Rev Rheumatol. 2022, 18:133-45. 10.1038\/s41584-021-00726-8","journal-title":"Nat Rev Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13688","article-title":"Upadacitinib: mechanism of action, clinical, and translational science","volume":"17","author":"Mohamed MF","year":"2024","unstructured":"Mohamed MF, Bhatnagar S, Parmentier JM, Nakasato P, Wung P. Upadacitinib: mechanism of action, clinical, and translational science. Clin Transl Sci. 2024, 17:e13688. 10.1111\/cts.13688","journal-title":"Clin Transl Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220822","article-title":"Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials","volume":"81","author":"Winthrop KL","year":"2022","unstructured":"Winthrop KL, Nash P, Yamaoka K, et al.. Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials. Ann Rheum Dis. 2022, 81:206-13. 10.1136\/annrheumdis-2021-220822","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d31e5c","article-title":"Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study","volume":"74","author":"Lin HC","year":"2010","unstructured":"Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010, 74:792-7. 10.1212\/WNL.0b013e3181d31e5c","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3137-2","article-title":"Varicella zoster virus infections in neurological patients: a clinical study","volume":"18","author":"Skripuletz T","year":"2018","unstructured":"Skripuletz T, Pars K, Schulte A, et al.. Varicella zoster virus infections in neurological patients: a clinical study. BMC Infect Dis. 2018, 18:238. 10.1186\/s12879-018-3137-2","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019132","article-title":"An approach to the diagnosis of acute transverse myelitis","volume":"28","author":"Jacob A","year":"2008","unstructured":"Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008, 28:105-20. 10.1055\/s-2007-1019132","journal-title":"Semin Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.04.017","article-title":"Features of varicella zoster virus myelitis and dependence on immune status","volume":"318","author":"Hung CH","year":"2012","unstructured":"Hung CH, Chang KH, Kuo HC, Huang CC, Liao MF, Tsai YT, Ro LS. Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci. 2012, 318:19-24. 10.1016\/j.jns.2012.04.017","journal-title":"J Neurol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden DH","year":"2000","unstructured":"Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000, 342:635-45. 10.1056\/NEJM200003023420906","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000350714","article-title":"Varicella zoster virus myelitis in two elderly patients: diagnostic value of nested polymerase chain reaction assay and antibody index for cerebrospinal fluid specimens","volume":"5","author":"Takahashi T","year":"2013","unstructured":"Takahashi T, Tamura M, Miki K, et al.. Varicella zoster virus myelitis in two elderly patients: diagnostic value of nested polymerase chain reaction assay and antibody index for cerebrospinal fluid specimens. Case Rep Neurol. 2013, 5:81-90. 10.1159\/000350714","journal-title":"Case Rep Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228323-varicella-zoster-meningitis-and-myelitis-after-herpes-zoster-dermatitis-treatment-with-amenamevir-a-case-series-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T23:02:17Z","timestamp":1708729337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228323-varicella-zoster-meningitis-and-myelitis-after-herpes-zoster-dermatitis-treatment-with-amenamevir-a-case-series-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.54775","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}